Articles published by Exicure, Inc.

< Previous 1 2 Next >

Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update

August 11, 2023

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update

July 14, 2023

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives

May 26, 2023

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q

May 19, 2023

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Announces Investment in Korean SNS Platform Cyworld

May 04, 2023

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors

April 27, 2023

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Reports Full Year 2022 Financial Results and Provides Corporate Update

March 27, 2023

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Announces Closing of Private Placement Transaction with CBI USA, Inc. and Changes to the Board of Directors

February 24, 2023

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements

December 14, 2022

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update

November 14, 2022

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Enters Into Definitive Agreement With CBI USA, Inc. for $5.4 Million Equity Financing and Announces Implementation of Strategic Measure to Reduce Cash Burn and Prioritize Strategic Alternatives

September 26, 2022

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure Announces Presentation at Chardan’s 6th Annual Genetic Medicines Conference

September 01, 2022

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Reports Second Quarter 2022 Financial Results and Corporate Progress

August 15, 2022

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement

July 20, 2022

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split

June 29, 2022

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Announces Adjournment of Annual Meeting of Stockholders

May 27, 2022

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure Announces Presentation at 2022 H.C. Wainwright Global Life Sciences Conference

May 17, 2022

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Reports First Quarter 2022 Financial Results and Corporate Progress

May 16, 2022

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure Announces $5 Million Raise in Private Placement Transaction Priced at Market Premium

May 10, 2022

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure to Present at Upcoming TIDES USA Oligonucleotide & Peptide Therapeutics Conference

May 09, 2022

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Reports Full Year 2021 Financial Results and Corporate Progress

March 25, 2022

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Announces Leadership Transition and Changes to the Board of Directors

February 04, 2022

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Announces $11.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

December 14, 2021

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Announces Results of Internal Investigation and Implementation of Strategic Measures to Reduce Cash Burn and Prioritize Pipeline Focus

December 10, 2021

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure, Inc. Reports Third Quarter 2021 Financial Results and Corporate Progress

November 19, 2021

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure Files Form 12b-25

November 15, 2021

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure to Present at Upcoming Scientific Conferences

October 28, 2021

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure to Present at Upcoming Scientific Conferences

October 07, 2021

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference

October 04, 2021

From Exicure, Inc.

Via Business Wire

Tickers XCUR

Exicure to Present at the Benzinga Healthcare Small Cap Conference

September 23, 2021

From Exicure, Inc.

Via Business Wire

Tickers XCUR

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.